- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Top 5 AJMC® Articles of August 2018
Here are the top 5 articles for the month of August.
Transcript:
Hi, I’m Jaime Rosenberg for The American Journal of Managed Care®. Here are the top 5 articles for the month of August.
Number 5: In a survey, employers indicated that they are taking a more activist role in delivering healthcare to their employees. They also expressed frustration with the pharmaceutical supply chain and said they expect to see a large uptake of virtual healthcare in the coming years.
Number 4: Ohio announced that it will end its contracts with all of its pharmacy benefit managers and start over with transparent ones.
Number 3: CMS announced that it will end the so-called 25% rule for long-term care hospitals and approved add-on payments estimated to cost about 72 million dollars for CAR T-cell therapy.
Number 2: Celyad’s Investigational New Drug application for CYAD-101 received FDA approval, making it the first non—gene-edited allogeneic clinical program for CAR T-cell therapy.
Number 1: During the Office of the National Coordinator for Health IT’s second Interoperability Forum, CMS administrator Seema Verma painted a future where health data follows the patient and can be shared with a doctor at the click of a button.
To read all of these articles and more, visit AJMC.com.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
